ArticleCurrent oncology (Toronto, Ont.)2022

TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.

Matthew S Ernst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.